These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32954237)

  • 1. High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria.
    Shiha MG; Ashgar Z; Fraser EM; Kurien M; Aziz I
    EClinicalMedicine; 2020 Aug; 25():100465. PubMed ID: 32954237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria.
    Aziz I; Mumtaz S; Bholah H; Chowdhury FU; Sanders DS; Ford AC
    Clin Gastroenterol Hepatol; 2015 Sep; 13(9):1650-5.e2. PubMed ID: 25769413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Black CJ; Yiannakou Y; Houghton LA; Ford AC
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.
    Goodoory VC; Houghton LA; Yiannakou Y; Black CJ; Ford AC
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):569-577.e3. PubMed ID: 33957271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
    World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.
    Oka P; Parr H; Barberio B; Black CJ; Savarino EV; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):908-917. PubMed ID: 32702295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
    Aziz I; Törnblom H; Palsson OS; Whitehead WE; Simrén M
    Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Black CJ; Craig O; Gracie DJ; Ford AC
    Gut; 2021 Jun; 70(6):1110-1116. PubMed ID: 32973070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey.
    Kosako M; Akiho H; Miwa H; Kanazawa M; Fukudo S
    Biopsychosoc Med; 2018; 12():18. PubMed ID: 30534195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.
    Edwards T; Friesen C; Schurman JV
    BMC Gastroenterol; 2018 Mar; 18(1):41. PubMed ID: 29549882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Aliment Pharmacol Ther; 2014 Feb; 39(3):312-21. PubMed ID: 24308816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders.
    Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; David Tai FW; Afify S; Aziz I
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):334-341.e3. PubMed ID: 32882424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.
    Mearin F; Balboa A; Badía X; Baró E; Caldwell E; Cucala M; Díaz-Rubio M; Fueyo A; Ponce J; Roset M; Talley NJ
    Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):165-72. PubMed ID: 12560761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
    Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irritable bowel syndrome in children with chronic gastrointestinal symptoms in primary care.
    Hogervorst EM; Ganzevoort IN; Berger MY; Holtman GA
    Fam Pract; 2024 Jun; 41(3):292-298. PubMed ID: 37392047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.
    Fairbrass KM; Selinger CP; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14256. PubMed ID: 34472157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome.
    Goodoory VC; Khasawneh M; Black CJ; Ford AC
    Clin Gastroenterol Hepatol; 2024 Feb; ():. PubMed ID: 38423348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of celiac disease among pediatric patients with irritable bowel syndrome: a 6-year prospective cohort study.
    Cristofori F; Fontana C; Magistà A; Capriati T; Indrio F; Castellaneta S; Cavallo L; Francavilla R
    JAMA Pediatr; 2014 Jun; 168(6):555-60. PubMed ID: 24756157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.